GSK Stock Holds Steady as RBC Starts Coverage, Barclays Cuts Target

GSK stock closed at GBX 1,796.50 on September 8, 2026, about 1.5% below its January opening price.

Royal Bank of Canada (RBC) initiated coverage with a Sector Perform rating and a GBX 1,975 price target, implying around 9.6% upside from the stock's prior close.

RBC analyst Trung Huynh believes strong share performance over the past year already reflects improved fundamentals and market confidence in new CEO Luke Miels' strategy.

In contrast, Barclays cut its GSK price target to GBP 18.00 per share while maintaining an Underweight rating, underscoring ongoing skepticism about upside potential.